Press Releases
After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States
-
Mon, 03-Jul-2023
- Posted by: Biocon Biologics
No Comments
Biocon Group concluded the month-long sustainability initiatives commemorating ‘World Environment Day’ initiated with ‘Nature Positive’ Campaign
-
Fri, 30-Jun-2023
- Posted by: Biocon Biologics
Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%
-
Tue, 23-May-2023
- Posted by: Biocon Biologics
Serum & Biocon Biologics Agree to Restructure Equity Investment
-
Tue, 25-Apr-2023
- Posted by: Biocon Biologics
Biocon Awarded a Silver Medal by EcoVadis for its Sustainability Accomplishments
-
Mon, 03-Apr-2023
- Posted by: Biocon Biologics
Biocon Biologics Wins the ‘ABEA : Bioprocessing Excellence in South Asia’ Award
-
Tue, 28-Mar-2023
- Posted by: Biocon Biologics
Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%
-
Thu, 09-Mar-2023
- Posted by: Biocon Biologics
Biocon Biologics Recognized as a Company with Great Managers; Two Managers conferred with individual ‘Great Managers Award 2022’
-
Thu, 22-Dec-2022
- Posted by: Biocon Biologics
Shreehas Tambe Appointed as Managing Director & CEO of Biocon Biologics Limited
-
Mon, 05-Dec-2022
- Posted by: Biocon Biologics
Biocon Biologics Completes Acquisition of Viatris’ Global Biosimilars Business
-
Tue, 29-Nov-2022
- Posted by: Biocon Biologics
